SVA vs REGN: Which Stock is Better?
Side-by-side comparison of Sinovac Biotech Ltd and Regeneron Pharmaceuticals Inc in 2026
SVA
Sinovac Biotech Ltd
—
REGN
Regeneron Pharmaceuticals Inc
$662.88
Key Metrics Comparison
| Metric | SVA | REGN | Winner |
|---|---|---|---|
| Market Cap | $642.44M | $59.10B | REGN |
| P/E Ratio | 6.66 | 13.91 | SVA |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SVA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SVA or REGN a better investment?
Comparing SVA and REGN: Sinovac Biotech Ltd has a market cap of $642.44M while Regeneron Pharmaceuticals Inc has $59.10B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SVA and REGN?
SVA (Sinovac Biotech Ltd) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SVA or REGN?
Based on P/E ratios, SVA trades at a lower multiple (6.7x vs 13.9x).
Which is growing faster: SVA or REGN?
Both SVA and REGN show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SVA or REGN?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SVA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $59.10B compared to $642.44M for SVA.
Should I buy SVA or REGN in 2026?
Both SVA and REGN have investment merit. SVA trades at $N/A while REGN trades at $662.88. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SVA and REGN stock?
Key differences: Market Cap ($642.44M vs $59.10B), P/E Ratio (6.7x vs 13.9x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SVA or REGN in 2026?
The choice between SVA and REGN depends on your investment goals. REGN shows higher revenue growth (0.0%). REGN has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SVA and REGN?
SVA (Sinovac Biotech Ltd) has a market cap of $642.44M, while REGN (Regeneron Pharmaceuticals Inc) has a market cap of $59.10B. REGN is the larger company by market value.